These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 19049901)

  • 21. Developing a drug-like natural product library.
    Quinn RJ; Carroll AR; Pham NB; Baron P; Palframan ME; Suraweera L; Pierens GK; Muresan S
    J Nat Prod; 2008 Mar; 71(3):464-8. PubMed ID: 18257534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The properties of known drugs. 1. Molecular frameworks.
    Bemis GW; Murcko MA
    J Med Chem; 1996 Jul; 39(15):2887-93. PubMed ID: 8709122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in computer-aided drug design.
    Song CM; Lim SJ; Tong JC
    Brief Bioinform; 2009 Sep; 10(5):579-91. PubMed ID: 19433475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quest for the rings. In silico exploration of ring universe to identify novel bioactive heteroaromatic scaffolds.
    Ertl P; Jelfs S; Mühlbacher J; Schuffenhauer A; Selzer P
    J Med Chem; 2006 Jul; 49(15):4568-73. PubMed ID: 16854061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guiding molecules towards drug-likeness.
    Egan WJ; Walters WP; Murcko MA
    Curr Opin Drug Discov Devel; 2002 Jul; 5(4):540-9. PubMed ID: 12197312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In silico screening of drug databases for TSE inhibitors.
    Lorenzen S; Dunkel M; Preissner R
    Biosystems; 2005 May; 80(2):117-22. PubMed ID: 15823410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping human metabolic pathways in the small molecule chemical space.
    Macchiarulo A; Thornton JM; Nobeli I
    J Chem Inf Model; 2009 Oct; 49(10):2272-89. PubMed ID: 19795883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinase-likeness and kinase-privileged fragments: toward virtual polypharmacology.
    Aronov AM; McClain B; Moody CS; Murcko MA
    J Med Chem; 2008 Mar; 51(5):1214-22. PubMed ID: 18288794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A practical view of 'druggability'.
    Keller TH; Pichota A; Yin Z
    Curr Opin Chem Biol; 2006 Aug; 10(4):357-61. PubMed ID: 16814592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A scoring scheme for discriminating between drugs and nondrugs.
    Sadowski J; Kubinyi H
    J Med Chem; 1998 Aug; 41(18):3325-9. PubMed ID: 9719584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination and mapping of activity-specific descriptor value ranges for the identification of active compounds.
    Eckert H; Bajorath J
    J Med Chem; 2006 Apr; 49(7):2284-93. PubMed ID: 16570925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates.
    Jónsdóttir SO; Jørgensen FS; Brunak S
    Bioinformatics; 2005 May; 21(10):2145-60. PubMed ID: 15713739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug- and lead-likeness, target class, and molecular diversity analysis of 7.9 million commercially available organic compounds provided by 29 suppliers.
    Chuprina A; Lukin O; Demoiseaux R; Buzko A; Shivanyuk A
    J Chem Inf Model; 2010 Apr; 50(4):470-9. PubMed ID: 20297844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can we learn to distinguish between "drug-like" and "nondrug-like" molecules?
    Ajay A; Walters WP; Murcko MA
    J Med Chem; 1998 Aug; 41(18):3314-24. PubMed ID: 9719583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diversity assessment.
    Mason JS; Hermsmeier MA
    Curr Opin Chem Biol; 1999 Jun; 3(3):342-9. PubMed ID: 10359714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circular fingerprints: flexible molecular descriptors with applications from physical chemistry to ADME.
    Glem RC; Bender A; Arnby CH; Carlsson L; Boyer S; Smith J
    IDrugs; 2006 Mar; 9(3):199-204. PubMed ID: 16523386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LASSOO: a generalized directed diversity approach to the design and enrichment of chemical libraries.
    Koehler RT; Dixon SL; Villar HO
    J Med Chem; 1999 Nov; 42(22):4695-704. PubMed ID: 10579831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How do metabolites differ from their parent molecules and how are they excreted?
    Kirchmair J; Howlett A; Peironcely JE; Murrell DS; Williamson MJ; Adams SE; Hankemeier T; van Buren L; Duchateau G; Klaffke W; Glen RC
    J Chem Inf Model; 2013 Feb; 53(2):354-67. PubMed ID: 23351040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural products as leads to potential drugs: an old process or the new hope for drug discovery?
    Newman DJ
    J Med Chem; 2008 May; 51(9):2589-99. PubMed ID: 18393402
    [No Abstract]   [Full Text] [Related]  

  • 40. Classifying 'drug-likeness' with kernel-based learning methods.
    Müller KR; Rätsch G; Sonnenburg S; Mika S; Grimm M; Heinrich N
    J Chem Inf Model; 2005; 45(2):249-53. PubMed ID: 15807485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.